Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of PSD502 for premature ejaculation
2007-003171-39Phase 3Completed
- Sponsor
- Plethora Solutions
- Start
- Oct 2007
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine + prilocaine in premature ejaculation (PE) (3 arms), sponsored by Plethora Solutions. Primary endpoints: Index of Premature Ejaculation (IPE) and Intravaginal ejaculatory latency time (IELT). Started Oct 2007; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2007-003171-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003171-39.